Spots Global Cancer Trial Database for prostatic cancer
Every month we try and update this database with for prostatic cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Far Infrared Radiation Treatment for Prostate Cancer | NCT00573820 | Prostatic Neopl... | Far Infrared Ra... | - | GAAD Medical Research Institute Inc. | |
| [68Ga]Ga-PSMA-11 PET/CT in the Assessment of High Risk and Recurrent Prostate Cancer | NCT04484701 | Prostatic Neopl... Prostatic Cance... | 68Ga-PSMA-11 | 19 Years - 99 Years | British Columbia Cancer Agency | |
| Quadratus Lumborum Block vs Transversus Abdominis Plane Block for Post-prostatectomy Analgesia | NCT03606889 | Prostatic Cance... Pain, Postopera... Pain Anesthetics, Lo... | Quadratus Lumbo... Tranversus Abdo... Bupivacaine | 18 Years - 90 Years | Jagiellonian University | |
| Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer | NCT00142506 | Prostate Cancer Erectile Dysfun... | sildenafil citr... placebo tablets... | - | Memorial Sloan Kettering Cancer Center | |
| Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors | NCT04541225 | Glioma Glioma, Maligna... Glioma, Mixed Glial Cell Tumo... Breast Cancer Breast Carcinom... Cancer of Breas... Cancer of the B... Breast Tumor Malignant Tumor... Advanced Breast... Advanced Breast... Metastatic Brea... Metastatic Brea... Prostate Cancer Prostatic Cance... Cancer of Prost... Cancer of the P... Prostate Neopla... Castrate Resist... Castration-resi... Castration Resi... Glioblastoma Recurrent Gliob... | NUV-422 | 18 Years - | Nuvation Bio Inc. | |
| Safety, Preliminary Efficacy and Pharmacokinetics of ASN001 in Metastatic Castrate Resistant Prostate Cancer | NCT02349139 | Cancer of the P... Neoplasms, Pros... Prostate Cancer Prostatic Cance... Neoplasms, Pros... Prostate Neopla... | ASN001: Escalat... | 18 Years - | Asana BioSciences | |
| Salvage HIFU for Local Recurrence in the Prostatic Bed After Prostatectomy and External Beam Radiation Therapy : Preliminary Results | NCT04421781 | Prostatic Cance... | Retrospectively... | 60 Years - 86 Years | Hospices Civils de Lyon | |
| Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPC | NCT05191017 | Prostate Cancer Prostatic Cance... Cancer of Prost... Cancer of the P... Prostate Neopla... Castrate Resist... Castration Resi... Castration Resi... | NUV-422 Enzalutamide | 18 Years - | Nuvation Bio Inc. | |
| High-dose Brachytherapy Boost With Stereostatic Body Radiation Therapy to Intermediate or Higher Risk Prostate Cancer | NCT05754580 | Prostatic Cance... | High Dose Brach... Stereostatic Bo... | 19 Years - | University of Nebraska | |
| Early Urinary Continence After Radical Prostatectomy: Surgical Procedure and Anatomic Landmarks | NCT04043637 | Prostatic Cance... Surgical Proced... Urinary Inconti... | 40 Years - 75 Years | Consorci Sanitari Integral | ||
| Open Anterograde Radical Prostatectomy Compared to Open Retrograde Technique | NCT02687308 | Prostatic Cance... Prostatic Neopl... | 1 Retrograde ra... 2 Anterograde r... | 40 Years - 80 Years | Rio de Janeiro State University | |
| CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose Distribution | NCT00643994 | Prostate Cancer Prostatic Cance... Prostate Neopla... Prostatic Neopl... Cancer of the P... | CyberKnife Ster... | 18 Years - | Accuray Incorporated | |
| A Study of Hansoh (HS)-10502 in Patients With Advanced Solid Tumors | NCT05740956 | Ovarian Cancer Breast Cancer Pancreatic Canc... Prostatic Cance... Colorectal Canc... | HS-10502 | 18 Years - 75 Years | Jiangsu Hansoh Pharmaceutical Co., Ltd. | |
| Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy | NCT03388619 | Cancer Of Prost... Prostate Neopla... Prostate Cancer Neoplasms of Pr... Prostatic Cance... | Prostate bed wi... Prostate bed ir... Whole Body Bone... 18F-NaF PET Ima... CT mpMRI ADT | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Optimizing the Effectiveness of Routine Post-treatment Surveillance in Prostate Cancer Survivors | NCT02957357 | Cancer of Prost... Cancer of the P... Prostate Cancer Prostatic Cance... | - | Alliance Foundation Trials, LLC. | ||
| To Evaluate LUTS and Complications Between Indwelling Catheter and Temporary Prostatic Stent in Patients Undergoing Minimally Invasive Procedures for the Treatment of Localized Prostate Cancer or Benign Prostatic Hyperplasia (HERMES) | NCT05851521 | Lower Urinary T... Prostatic Hyper... Prostatic Cance... Urinary Retenti... | Temporary prost... Indwelling cath... | 18 Years - 85 Years | Lyx Institute | |
| Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPC | NCT05191017 | Prostate Cancer Prostatic Cance... Cancer of Prost... Cancer of the P... Prostate Neopla... Castrate Resist... Castration Resi... Castration Resi... | NUV-422 Enzalutamide | 18 Years - | Nuvation Bio Inc. | |
| LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology | NCT05184790 | Arrhythmias, Ca... Breast Cancer Prostatic Cance... Brain Cancer Kidney Cancer Head and Neck C... Liver Cancer Pancreatic Canc... Spinal Neoplasm | 18 Years - | University of Sydney | ||
| To Evaluate the Technique and Effects of Separating the Prostate and Rectum With Hyaluronic Acid During Radiotherapy | NCT01787630 | Prostatic Cance... | Hyaluronic acid | 18 Years - 75 Years | Umeå University | |
| Fusion Versus Cognitive MRI Targeted Prostatic Biopsy | NCT05969704 | Prostatic Cance... | MRI fusion targ... MRI cognitive t... | - | Menoufia University | |
| North Carolina Prostate Cancer Comparative Effectiveness & Survivorship Study (NC ProCESS) | NCT02564120 | Cancer of Prost... Cancer of the P... Prostate Cancer Prostatic Cance... | 35 Years - 80 Years | UNC Lineberger Comprehensive Cancer Center | ||
| 18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer | NCT03181867 | Prostate Neopla... Prostatic Cance... Prostate Cancer Cancer Of Prost... Metastatic Pros... | 18F-DCFPyL 18F-FDG PSMA-11 | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| A Study for the Treatment of Hormone Refractory Prostate Cancer (HRPC) in Patients Previously Treated With Chemotherapy | NCT00257478 | Prostate Cancer Cancer of Prost... Prostatic Cance... Cancer of the P... | YM155 | 18 Years - | Astellas Pharma Inc | |
| Clinical Trial to Examine Individual Pain Tolerance in the Use of Two Anesthetic Techniques to Perform Saturation Prostate Biopsy | NCT02909049 | Prostatic Cance... | MIDAZOLAM MEPIVACAÍNE FENTANILE KETAMINE | 18 Years - 75 Years | Complexo Hospitalario Universitario de A Coruña | |
| Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancer | NCT00970203 | Cancer of Prost... Cancer of the P... Neoplasms, Pros... Neoplasms, Pros... Prostate Cancer Prostate Neopla... Prostatic Cance... | androgen ablati... DC1 vaccine | 18 Years - | Roswell Park Cancer Institute | |
| 68Ga-labeled NY108 PET Imaging in Patients | NCT05623878 | Prostatic Cance... | 68Ga-labeled NY... | 18 Years - 75 Years | Affiliated Hospital of Jiangnan University | |
| Prostate Cancer Risk in Firefighters | NCT03893123 | Prostatic Cance... | Observational s... | - | Oslo University Hospital | |
| Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer | NCT00142506 | Prostate Cancer Erectile Dysfun... | sildenafil citr... placebo tablets... | - | Memorial Sloan Kettering Cancer Center | |
| Sipuleucel-T Manufacturing Demonstration Study | NCT01477749 | Cancer of Prost... Cancer of the P... Neoplasms, Pros... Neoplasms, Pros... Prostate Cancer Prostate Neopla... Prostatic Cance... | sipuleucel-T | 18 Years - | Dendreon | |
| Fusion Versus Cognitive MRI Targeted Prostatic Biopsy | NCT05969704 | Prostatic Cance... | MRI fusion targ... MRI cognitive t... | - | Menoufia University | |
| Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors | NCT04541225 | Glioma Glioma, Maligna... Glioma, Mixed Glial Cell Tumo... Breast Cancer Breast Carcinom... Cancer of Breas... Cancer of the B... Breast Tumor Malignant Tumor... Advanced Breast... Advanced Breast... Metastatic Brea... Metastatic Brea... Prostate Cancer Prostatic Cance... Cancer of Prost... Cancer of the P... Prostate Neopla... Castrate Resist... Castration-resi... Castration Resi... Glioblastoma Recurrent Gliob... | NUV-422 | 18 Years - | Nuvation Bio Inc. | |
| Efficacy Study of ABR-215050 to Treat Prostate Cancer | NCT00560482 | Prostate Cancer | ABR-215050, tas... Placebo | 18 Years - | Active Biotech AB | |
| Quadratus Lumborum Block vs Transversus Abdominis Plane Block for Post-prostatectomy Analgesia | NCT03606889 | Prostatic Cance... Pain, Postopera... Pain Anesthetics, Lo... | Quadratus Lumbo... Tranversus Abdo... Bupivacaine | 18 Years - 90 Years | Jagiellonian University | |
| Study to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cancer Tumors | NCT00511576 | Breast Cancer Lung Cancer Pulmonary Cance... Non-Small-Cell ... Prostate Cancer Prostatic Cance... Gastric Cancer Stomach Cancer | MGCD0103 & Doce... | 18 Years - | Mirati Therapeutics Inc. | |
| Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancer | NCT00970203 | Cancer of Prost... Cancer of the P... Neoplasms, Pros... Neoplasms, Pros... Prostate Cancer Prostate Neopla... Prostatic Cance... | androgen ablati... DC1 vaccine | 18 Years - | Roswell Park Cancer Institute | |
| [68Ga]Ga-PSMA-11 PET/CT in the Assessment of High Risk and Recurrent Prostate Cancer | NCT04484701 | Prostatic Neopl... Prostatic Cance... | 68Ga-PSMA-11 | 19 Years - 99 Years | British Columbia Cancer Agency | |
| North Carolina Prostate Cancer Comparative Effectiveness & Survivorship Study (NC ProCESS) | NCT02564120 | Cancer of Prost... Cancer of the P... Prostate Cancer Prostatic Cance... | 35 Years - 80 Years | UNC Lineberger Comprehensive Cancer Center | ||
| Autologous Dendritic Cell Therapy for Hormone-Refractory Metastatic Prostate Cancer | NCT01171729 | Prostatic Cance... | Autologous dend... | 18 Years - | Samsung Medical Center | |
| Metabolic Changes in Prostate Cancer Patients With Androgen-ablation Therapy (AAT) | NCT01284608 | Prostatic Cance... | 18 Years - | AstraZeneca | ||
| Effect of Adding Sufentanil to Epidural Ropivacaine on Perioperative Metabolic and Stress Responses in Combined General/Epidural Anaesthesia for Geriatric Radical Retropubic Prostatectomy | NCT01086956 | Prostatic Cance... | epidural infusi... | 65 Years - | Yonsei University | |
| CyberKnife Radiosurgery for Localized Prostatic Carcinoma | NCT01045148 | Prostate Cancer | CyberKnife Radi... CyberKnife Radi... | 18 Years - | CyberKnife Centers of San Diego | |
| Dynamic Whole Body PET/ MRI | NCT04495959 | Prostatic Cance... | 68Ga-HTK03149 | 19 Years - 99 Years | British Columbia Cancer Agency | |
| Stereotactic Body Radiotherapy for Stage I-III Prostate Cancer | NCT02334579 | Prostate Cancer Prostatic Cance... Prostate Neopla... Prostatic Neopl... Cancer of the P... | CyberKnife Ster... | 18 Years - | Swedish Medical Center | |
| Study of Anatomic Nerve Sparing Radical Perineal Prostatectomy | NCT00922818 | Prostate Cancer | 18 Years - | Maimonides Medical Center | ||
| Far Infrared Radiation Treatment for Prostate Cancer | NCT00573820 | Prostatic Neopl... | Far Infrared Ra... | - | GAAD Medical Research Institute Inc. | |
| CyberKnife Radiosurgery for Localized Prostatic Carcinoma | NCT01045148 | Prostate Cancer | CyberKnife Radi... CyberKnife Radi... | 18 Years - | CyberKnife Centers of San Diego | |
| Salvage HIFU for Local Recurrence in the Prostatic Bed After Prostatectomy and External Beam Radiation Therapy : Preliminary Results | NCT04421781 | Prostatic Cance... | Retrospectively... | 60 Years - 86 Years | Hospices Civils de Lyon | |
| Prostate Cancer Risk in Firefighters | NCT03893123 | Prostatic Cance... | Observational s... | - | Oslo University Hospital | |
| Quinacrine Treatment in Patients With Androgen-Independent Prostate Cancer | NCT00417274 | Prostatic Cance... | Quinacrine | 18 Years - | Cleveland BioLabs | |
| Autologous Dendritic Cell Therapy for Hormone-Refractory Metastatic Prostate Cancer | NCT01171729 | Prostatic Cance... | Autologous dend... | 18 Years - | Samsung Medical Center | |
| Prevention of Urinary Incontinence After Prostatectomy | NCT00982098 | Urinary Inconti... | BioFeedback; Fu... | 18 Years - | Azienda Ospedaliero Universitaria Maggiore della Carita | |
| Clinical Trial to Examine Individual Pain Tolerance in the Use of Two Anesthetic Techniques to Perform Saturation Prostate Biopsy | NCT02909049 | Prostatic Cance... | MIDAZOLAM MEPIVACAÍNE FENTANILE KETAMINE | 18 Years - 75 Years | Complexo Hospitalario Universitario de A Coruña | |
| Sipuleucel-T Manufacturing Demonstration Study | NCT01477749 | Cancer of Prost... Cancer of the P... Neoplasms, Pros... Neoplasms, Pros... Prostate Cancer Prostate Neopla... Prostatic Cance... | sipuleucel-T | 18 Years - | Dendreon | |
| CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry | NCT00643617 | Prostate Cancer Prostatic Cance... Prostatic Neopl... Prostate Neopla... Cancer of the P... | CyberKnife Ster... CyberKnife Ster... | 18 Years - | Accuray Incorporated | |
| [68Ga]Ga-PSMA-11 PET/CT in the Assessment of High Risk and Recurrent Prostate Cancer | NCT04484701 | Prostatic Neopl... Prostatic Cance... | 68Ga-PSMA-11 | 19 Years - 99 Years | British Columbia Cancer Agency | |
| Prothrombotic Factors and Anaesthesia in Prostate Cancer | NCT01998685 | Prostatic Cance... Surgery | Propofol remifentanyl Midazolam Fentanyl Sevoflurane | 40 Years - 80 Years | Regina Elena Cancer Institute | |
| 18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer | NCT03181867 | Prostate Neopla... Prostatic Cance... Prostate Cancer Cancer Of Prost... Metastatic Pros... | 18F-DCFPyL 18F-FDG PSMA-11 | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| [68Ga]Ga-PSMA-11 PET/CT in the Assessment of High Risk and Recurrent Prostate Cancer | NCT04484701 | Prostatic Neopl... Prostatic Cance... | 68Ga-PSMA-11 | 19 Years - 99 Years | British Columbia Cancer Agency | |
| Optimizing the Effectiveness of Routine Post-treatment Surveillance in Prostate Cancer Survivors | NCT02957357 | Cancer of Prost... Cancer of the P... Prostate Cancer Prostatic Cance... | - | Alliance Foundation Trials, LLC. | ||
| Safety, Preliminary Efficacy and Pharmacokinetics of ASN001 in Metastatic Castrate Resistant Prostate Cancer | NCT02349139 | Cancer of the P... Neoplasms, Pros... Prostate Cancer Prostatic Cance... Neoplasms, Pros... Prostate Neopla... | ASN001: Escalat... | 18 Years - | Asana BioSciences | |
| Low Dose Supplemental External Radiation With Pd-103 Versus Pd-103 Alone for Prostate Cancer | NCT00241384 | Prostate Cancer | External beam r... Pd-103 | 40 Years - 80 Years | Schiffler Cancer Center | |
| Safety, Preliminary Efficacy and Pharmacokinetics of ASN001 in Metastatic Castrate Resistant Prostate Cancer | NCT02349139 | Cancer of the P... Neoplasms, Pros... Prostate Cancer Prostatic Cance... Neoplasms, Pros... Prostate Neopla... | ASN001: Escalat... | 18 Years - | Asana BioSciences |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
